AU2002242636A1 - High throughput determination of antigen expression - Google Patents

High throughput determination of antigen expression

Info

Publication number
AU2002242636A1
AU2002242636A1 AU2002242636A AU4263602A AU2002242636A1 AU 2002242636 A1 AU2002242636 A1 AU 2002242636A1 AU 2002242636 A AU2002242636 A AU 2002242636A AU 4263602 A AU4263602 A AU 4263602A AU 2002242636 A1 AU2002242636 A1 AU 2002242636A1
Authority
AU
Australia
Prior art keywords
high throughput
antigen expression
throughput determination
determination
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002242636A
Other languages
English (en)
Inventor
Antonio Cosma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNOCLIN LABORATORIES Ltd
Original Assignee
IMMUNOCLIN LAB Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUNOCLIN LAB Ltd filed Critical IMMUNOCLIN LAB Ltd
Publication of AU2002242636A1 publication Critical patent/AU2002242636A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552—Glass or silica

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002242636A 2000-11-27 2001-11-27 High throughput determination of antigen expression Abandoned AU2002242636A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25370600P 2000-11-27 2000-11-27
US60/253,706 2000-11-27
PCT/EP2001/014767 WO2002046757A2 (fr) 2000-11-27 2001-11-27 Determination a haut rendement de l'expression d'antigenes

Publications (1)

Publication Number Publication Date
AU2002242636A1 true AU2002242636A1 (en) 2002-06-18

Family

ID=22961376

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002242636A Abandoned AU2002242636A1 (en) 2000-11-27 2001-11-27 High throughput determination of antigen expression

Country Status (3)

Country Link
US (1) US20020137104A1 (fr)
AU (1) AU2002242636A1 (fr)
WO (1) WO2002046757A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2386372A (en) * 2002-03-13 2003-09-17 Amersham Biosciences Uk Ltd The use of organic solvents in the preparation of arrays
EP1572116A4 (fr) * 2002-11-26 2007-12-12 Genentech Inc Compositions et procedes destines au traitement de maladies de nature immune
US20060205089A1 (en) * 2003-04-14 2006-09-14 Montana State University Mapping discontinuous antibody or aptamer epitopes for protein structure determination and other applications
US8632983B2 (en) 2005-04-15 2014-01-21 Van Andel Research Institute Biomarkers for pancreatic cancer and diagnostic methods
US7838634B2 (en) * 2005-04-15 2010-11-23 Van Andel Research Institute Methods for measuring glycan levels of proteins
WO2010141421A1 (fr) 2009-06-02 2010-12-09 The Board Of Regents Of The University Of Texas System Identification de petites molécules reconnues par des anticorps chez des sujets atteints de maladies neurodégénératives
WO2011047257A1 (fr) 2009-10-16 2011-04-21 The Board Of Regents Of The University Of Texas System Compositions et procédés de production de banques de peptoïdes cycliques
US10753936B2 (en) 2016-07-22 2020-08-25 Van Andel Research Institute Method of detecting the level of a glycan

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300425A (en) * 1987-10-13 1994-04-05 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
US6066718A (en) * 1992-09-25 2000-05-23 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
WO1999040434A1 (fr) * 1998-02-04 1999-08-12 Invitrogen Corporation Microsystemes et leurs mises en application
US6150123A (en) * 1998-09-03 2000-11-21 Centre Integre De Recherches Biocliniques Sur Le Sida (Cirbs) Affinity biotinylation

Also Published As

Publication number Publication date
WO2002046757A2 (fr) 2002-06-13
WO2002046757A3 (fr) 2003-04-10
US20020137104A1 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AU2001259624A1 (en) Modulation of antigen processing using phagocytic cells
AU2002351623A1 (en) Streptococcus antigens
AU2001294175A1 (en) Method of purifying antibody
AU2001283307A1 (en) Hydrocarbon gas processing
AU2001234125A1 (en) Antibody library
AU2002354929A1 (en) Antibodies specific for nanotubes and related methods and compositions
AU2002365649A1 (en) Anti-dota antibody
AU2001290860A1 (en) Spas-1 cancer antigen
AU2001275007A1 (en) Methods of testing materials
AU2001246934A1 (en) Agonist antibodies
AU2002315066A1 (en) Methods for making antibody fragments and compositions resulting therefrom
AU2002242636A1 (en) High throughput determination of antigen expression
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
AU2002216847A1 (en) Epitopes of pai-1
AU2001295582A1 (en) Tumour-related antigens
AU2002221132A1 (en) Novel antibody
AU2001245950A1 (en) Preparation of deoxynucleosides
AU5647501A (en) Crystallography methods
AU2001276523A1 (en) Aspiration of samples
AU2001266409A1 (en) Cosmetic sample bottle
AU2001244863A1 (en) Apoptin-associating protein
AU2001271033A1 (en) Means of assaying immune function
AU2001262589A1 (en) Glycosyltransferase proteins
AU2000258438A1 (en) An improved process for the preparation of acylferrocenes